News

Generic atorvastatin recall applies to 90-count bottles of 10-mg tablets


 

More than 64,000 bottles of 10-mg generic atorvastatin tablets have been recalled, according to a notice on the Food and Drug Administration website.

The nationwide recall applies to 64,626 bottles that contain 90 tablets, and are manufactured by Ranbaxy Pharmaceuticals. The discovery of a 20-mg atorvastatin tablet in a sealed 90-count bottle of atorvastatin 10-mg tablets was the basis of the recall.

The recall is voluntary and was initiated by Ranbaxy in January 2014.

The affected bottles are pharmacy dispensing bottles, a Ranbaxy spokesperson said.

Lipitor is the brand-name version of atorvastatin.

emechcatie@frontlinemedcom.com

Recommended Reading

Higher PCI risk in diabetes not due to insulin
MDedge Cardiology
PCSK9 antibody shows safety, efficacy to 1 year
MDedge Cardiology
Former JNC 8 hypertension panel issues minority report
MDedge Cardiology
Bad breakfasts cast a long shadow
MDedge Cardiology
FDA investigating testosterone’s cardiovascular risks
MDedge Cardiology
Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes
MDedge Cardiology
Too much dietary sugar raises CVD mortality
MDedge Cardiology
New stroke guidelines focus on women’s risks
MDedge Cardiology
Endocrine Society calls for trials on testosterone’s cardiovascular effects
MDedge Cardiology
FDA to probe saxagliptin’s heart failure risk
MDedge Cardiology